Propofol and Dexmedetomidin vs Midazolam Intraoperative Sedation and POCD
NCT05398757 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL
Last updated 2024-09-19
Summary
This study will examine the effect of intraoperative sedation with midazolam, propofol and dexemdetomidine on the occurrence of postoperative cognitive impairment in patients undergoing surgical treatment of pertrochanteric fracture of the femur.
Conditions
- Postoperative Cognitive Dysfunction
- Postoperative Pain, Acute
- Pertrochanteric Fracture
Interventions
- BEHAVIORAL
-
Mini mental state exame (MMSE)
Before the operation, and on the 1st, 3rd and 5th day after the operation, the Mini mental state exam (MMSE) score will be measured
- BEHAVIORAL
-
Digit Symbol Substitution Test (DSST)
Before the operation, and on the 1st, 3rd and 5th day after the operation, the Digit Symbol Substitution Test (DSST) score will be measured
- DIAGNOSTIC_TEST
-
Numeric rating Scale (NRS)
4h, 8h, 12h and 24h after surgery, pain in all patients will be assessed by the NRS scale.
- DIAGNOSTIC_TEST
-
Postoperative inflammation
All patients included in the study will have their blood taken for laboratory analysis of red blood cells, leukocytes, CRP, PCT, ChE and IL-6. Analyzes will be performed before the procedure, on the 1st, 3rd and 5th postoperative day.
- DRUG
-
Midazolam
For sedation during surgery, patients in midazolam group will receive i.v. midazolam in dose 0.05 - 0.07 mg/kg after spinal anesthesia.
- DRUG
-
Propofol
For sedation during surgery, patients in propofol group will receive i.v. propofol in dose 25-27 mcg/kg/min.
- DRUG
-
Dexmedetomidin
For sedation during surgery, patients in dexmedetomidin gropu will receive i.v. dexmedetomidin in dose 0.5 mcg/kg/h
Sponsors & Collaborators
-
Josip Juraj Strossmayer University of Osijek
collaborator OTHER -
Osijek University Hospital
lead OTHER
Principal Investigators
-
Nenad Neskovic, PhD · University Hospital Osijek
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-07-01
- Primary Completion
- 2024-03-01
- Completion
- 2024-03-01
Countries
- Croatia
Study Locations
More Related Trials
-
Dexmedetomidine Sedation in Orthopedic Surgery
NCT04149626 ·Status: UNKNOWN ·Phase: PHASE2
-
Comparison of Recovery Profiles Among Propofol, Remimazolam, and Dexmedetomidine After Intraoperative Sedation
NCT05688345 ·Status: COMPLETED ·Phase: PHASE4
-
A Comparison Between Dexmedetomidine and Propofol-fentanyl Infusions for Sedation for Colonoscopy Procedures
NCT06148103 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Effect of Appropriate Sedation for Patients After Gastrectomy: A Prospective Randomised Controlled Study
NCT02674737 ·Status: UNKNOWN ·Phase: NA
-
Pharmacodynamic Interactions of Propofol and Dexmedetomidine on Intravenous Anesthesia
NCT02777619 ·Status: COMPLETED ·Phase: PHASE4
-
Safety Study of Dexmedetomidine in Elderly Under General Anesthesia
NCT05567523 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of Dexmedetomidine on Postoperative Neurocognitive Disorder
NCT06689137 ·Status: ACTIVE_NOT_RECRUITING
-
Sedation by Dexmedetomidine and Propofol
NCT02993718 ·Status: COMPLETED ·Phase: NA
-
Can Dexmedetomidine For Procedural Sedation In Knee Arthroplasty Reduce Postoperative Pain? A Randomized Control Study
NCT02026141 ·Status: COMPLETED ·Phase: PHASE4
-
Impact of Dexmedetomidine on the Post-Operative Cognition Dysfunction(POCD) in Geriatric Patients
NCT02275182 ·Status: COMPLETED ·Phase: PHASE4
-
Nocturnal Low-dose Dexmedetomidine Infusion and Perioperative Sleep Quality
NCT05246007 ·Status: WITHDRAWN ·Phase: NA
-
Dexmedetomidine and Postoperative Cognitive Dysfunction (POCD)
NCT06371638 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of Remimazolam and Dexmedetomidine for Intraoperative Sedation
NCT05447507 ·Status: COMPLETED ·Phase: PHASE4
-
Dexmedetomidine on Postoperative Cognitive Dysfunction and Serum Tau-217 Protein.
NCT06366412 ·Status: RECRUITING ·Phase: PHASE4
-
Effect of Intravenous Dexmedetomidine on Analgesic Duration of Infraclavicular Block
NCT01981369 ·Status: COMPLETED ·Phase: NA
-
Dexmedetomidine Use in ICU Sedation and Postoperative Recovery in Elderly Patients and Post-cardiac Surgery
NCT02699801 ·Status: UNKNOWN ·Phase: NA
-
Cognitive Outcomes After Dexmedetomidine Sedation in Cardiac Surgery Patients
NCT04289142 ·Status: RECRUITING ·Phase: PHASE4
-
Cognitive Functions After TIVA With Dexmedetomidine
NCT02631135 ·Status: COMPLETED ·Phase: PHASE4
-
Intraoperative Sedatives and Postoperative Pain
NCT02784626 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of the Effect of Appropriate Sedation for Patients After Abdominal Surgeries : A Prospective Randomised Controlled Study
NCT02670954 ·Status: COMPLETED ·Phase: NA
-
Conscious Sedation for Outpatient Colonoscopy
NCT03925779 ·Status: COMPLETED ·Phase: PHASE2
-
A Research Study to Evaluate the Effectiveness of Dexmedetomidine in Preventing Delirium After Hip Fracture Repair Surgery
NCT00460473 ·Status: TERMINATED ·Phase: PHASE3
-
Perioperative Cognitive Function - Dexmedetomidine and Cognitive Reserve
NCT00561678 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Intraoperative Dexmedetomidine on Early Postoperative Cognitive Dysfunction
NCT03793751 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Dexmedetomidine on Propofol Requirement During Anesthesia
NCT02599168 ·Status: COMPLETED ·Phase: PHASE4